KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Chemed (CHE) Accumulated Depreciation & Amortization (2016 - 2025)

Chemed filings provide 16 years of Accumulated Depreciation & Amortization readings, the most recent being $388.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 1.6% year-over-year to $388.1 million, compared with a TTM value of $388.1 million through Dec 2025, up 1.6%, and an annual FY2025 reading of $388.1 million, up 1.6% over the prior year.
  • Accumulated Depreciation & Amortization hit $388.1 million in Q4 2025 for Chemed, up from $382.0 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $388.1 million in Q4 2025, with the low at $317.9 million in Q4 2021.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $354.9 million (2023), compared with a mean of $355.8 million.
  • The sharpest move saw Accumulated Depreciation & Amortization increased 8.36% in 2021, then grew 1.6% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $317.9 million in 2021, then grew by 5.66% to $335.9 million in 2022, then increased by 5.64% to $354.9 million in 2023, then grew by 7.64% to $382.0 million in 2024, then increased by 1.6% to $388.1 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $388.1 million, $382.0 million, and $354.9 million for Q4 2025, Q4 2024, and Q4 2023 respectively.